Clinical Trials for Adverum Biotechnologies

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Adverum Biotechnologies

Clinical Trials (4)

NCT06856577
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
PHASE3Recruiting
284 participants
Started: Feb 28, 2025 · Completed: Mar 25, 2030
2 conditions1 sponsor79 locations
NCT05536973
Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]
PHASE2Active, not recruiting
69 participants
Started: Aug 23, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor39 locations
NCT05607810
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
N/AActive, not recruiting
22 participants
Started: Aug 10, 2022 · Completed: Apr 30, 2026
2 conditions1 sponsor7 locations
NCT04645212
Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]
N/AActive, not recruiting
23 participants
Started: Dec 14, 2020 · Completed: Jun 30, 2025
2 conditions1 sponsor9 locations